Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Expressor DLBCL”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Looking for participantsNCT07493148
What this trial is testing

Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD 50
Testing effectiveness (Phase 2)Looking for participantsNCT06736613
What this trial is testing

Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Testing effectiveness (Phase 2)Looking for participantsNCT06674096
What this trial is testing

RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

Who this might be right for
Double-expressor Lymphoma
Zhejiang Cancer Hospital 44
Large-scale testing (Phase 3)Study completedNCT04231448
What this trial is testing

Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Chipscreen Biosciences, Ltd. 423
Testing effectiveness (Phase 2)WithdrawnNCT03241017
What this trial is testing

Durvalumab in DLBCL After Autologous Transplant

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Insel Gruppe AG, University Hospital Bern
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507318
What this trial is testing

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Who this might be right for
Diffuse Large B-Cell Lymphoma
Rong Tao 69
Not applicableNot Yet RecruitingNCT06652152
What this trial is testing

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)Double Expressor Lymphoma
Ruijin Hospital 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415980
What this trial is testing

Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL

Who this might be right for
Double Expressor DLBCL
Sun Yat-sen University 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07511114
What this trial is testing

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaDouble Expressor Lymphoma
Ruijin Hospital 156
Early research (Phase 1)Study completedNCT01742988
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Who this might be right for
LymphomaRelapsed LymphomaRefractory Lymphoma+8 more
Curis, Inc. 106
Testing effectiveness (Phase 2)Looking for participantsNCT06891157
What this trial is testing

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

Who this might be right for
ChidamideR-CHOP ChemotherapyDLBCL - Diffuse Large B Cell Lymphoma+1 more
The First Affiliated Hospital with Nanjing Medical University 148